Mathew Aby J. sold BLFS

September 11, 2025 · Form 4 insider transaction

Mathew Aby J. sold 630 shares of BioLife Solutions, Inc. at $26.83 per share, a transaction worth $16.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
630
Price
$26.83
Total value
$16.9K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 11, 2025
Filing dateSeptember 15, 2025
Shares owned after351,421
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

View the original Form 4 on SEC EDGAR